Morgan Stanley Maintains Equal-Weight on Hims & Hers Health, Lowers Price Target to $25
Benzinga Newsdesk 4 hours ago
Analyst RatingsNewsPrice Target
Morgan Stanley analyst Craig Hettenbach maintains Hims & Hers Health (NYSE:HIMS) with a Equal-Weight and lowers the price target from $28 to $25.
Morgan Stanley analyst Craig Hettenbach maintains Hims & Hers Health (NYSE:HIMS) with a Equal-Weight and lowers the price target from $28 to $25.